Recent studies showed that the ability of intrahepatic NK cells defined as CD45+ CD3− CD56+ T-bethi Eomeslo to degranulate and their killing activity was inversely correlated with the severity of NAFLD/NASH, and also the liver-resident NK cells defined as CD45+ CD3− CD56+ T-betlo Eomeshi exhibited decreased ability to degranulate (72). The gene discussed is NCAM1; the disease is metabolic dysfunction-associated steatohepatitis.